PALO ALTO, Calif — August 13, 2020 — CB Insights today named Avail Medsystems to its second annual Digital Health 150 ranking, which showcases the 150 most promising private digital health companies in the world.
The 2020 Digital Health 150 cohort highlights startups that are reimagining the lines of the traditional healthcare experience across 12 categories, from Virtual Care Delivery and Clinical Trials, to Drug Discovery and Specialty Care. Countries represented this year include Canada, China, Israel, France, the United Kingdom, and the United States, among others.
“This year’s Digital Health 150 is our most global ever, covering the best private healthcare companies from 17 countries. Beyond geographic diversity, these companies are innovating across the entire healthcare value chain, spanning technologies that benefit pharma & biotech companies, to payers, hospitals, insurers, and more,” said CB Insights CEO Anand Sanwal. “Last year’s Digital Health 150 winners saw numerous exits and went on to raise nearly $5 billion in investor financing after being recognized. We look forward to seeing the success of this year’s class of the best in digital health.”
Avail Medsystems is a medical technology company pioneering telemedicine for the procedure room (“Procedural TelemedicineTM”), which allows healthcare professionals and medical industry advisors to share expertise remotely via advanced audio/video technology and an intuitive user experience built for mobility. Over the past three years, Avail has leveraged more than 400 years of combined medical technology development, sales and marketing experience to create its Procedural TelemedicineTM System, so industry experts and healthcare professionals can provide support, train and share knowledge during live procedures – from anywhere. Now, as the COVID-19 pandemic compels healthcare providers to limit in-person procedure support, Avail’s purpose-built solution has become a tool of necessity enabling care providers, and the experts who support them, to continue collaborating during medical procedures regardless of location.
“It’s an honor to be named to the CB Insights Digital Health 150 list in recognition of Avail’s pioneering Procedural TelemedicineTM solution and our mission to remove the barriers of in-person procedure support and training,” said Avail CEO Daniel Hawkins. “We developed the Avail System to provide universal access to clinical and procedural expertise, regardless of location. We’re continuing to innovate and expand our product offerings, most recently with the launch of the Avail Portal which provides users multi-platform access to the Avail Network and enables enhanced management of remote collaboration activities. Collectively, our solutions provide significant benefits to industry experts, medical device representatives, physicians and surgeons — particularly in the ‘new normal’ of COVID-19.”
Through an evidence-based approach, the CB Insights research team selected the Digital Health 150 from hundreds of applications based on several factors including patent activity, investor quality, news sentiment analysis, proprietary Mosaic scores, market potential, partnerships, competitive landscape, team strength, and tech novelty. The Mosaic Score, based on CB Insights’ algorithm, measures the overall health and growth potential of private companies to help predict a company’s momentum.
Quick facts on the 2020 Digital Health 150:
- The 2020 Digital Health 150 startups have raised over $20B in funding across 600+ deals from 900+ unique investors.
- The list includes 13 unicorns (companies that have reached a valuation of $1B+) focused on a diverse range of digital health solutions, including telehealth, insurance, and robotic surgical systems.
- Many have formed partnerships with key industry players like the American Heart Association, Cigna, and Mount Sinai Health System.
The Digital Health 150 Companies (in alphabetical order):
|98Point6||Abacus Insights||AbCellera Biologics|
|Aetion||Akili Interactive Labs||Alan|
|Atomwise||Avail Medsystems||Axial Healthcare|
|Babyscripts||Bend Financial||Bigfoot Biomedical|
|Brightside Benefit||Cala Health||Capsule|
|Caption Health||Carbon Health||Carrot Fertility|
|Cityblock Health||CMR Surgical||Concerto HealthAI|
|Cricket Health||Cue Health||CureApp|
|Current Health||Dental Monitoring||Devoted Health|
|Doctor On Demand||Dreem||Eko|
|Element Science||Evidation Health||Firefly Health|
|Folx Health||Freenome||Galileo Health|
|Healx||Heartbeat||Hims & Hers|
|Insilico Medicine||Insitro||Iora Health|
|K Health||Kaia Health||Karius|
|Mammoth Biosciences||Maven Clinic||Medable|
|Medbanks Network Technology||Medically Home Group||MediTrust Health|
|Modern Fertility||Mojo Vision||nference|
|Omada Health||Oncology Analytics||Onera Health|
|Saama Technologies||Science 37||Sema4|
|Subtle Medical||Taimei Technology||Talkspace|
|Tempus||Tencent Trusted Doctors||Thrive Earlier Detection|
|Valencell||Verana Health||Vesta Healthcare|
|We Doctor||Wellth||Winterlight Labs|
|Xealth||XtalPi||Zebra Medical Vision|
About Avail Medsystems
Avail Medsystems is a pioneering medical technology company that removes the barriers of in-person medical procedure collaboration. With a customer-centric business model, Avail’s purpose-built Procedural TelemedicineTM technology enables on-the-go, HIPAA compliant collaboration among a network of healthcare professionals and industry experts.
For more information about Avail Medsystems, visit Avail.io and follow us on Twitter or LinkedIn.
About CB Insights
At CB Insights, we believe the most complex strategic business questions are best answered with facts. We are a machine intelligence company that synthesizes, analyzes and visualizes millions of documents to give our clients fast, fact-based insights. Serving the majority of the Fortune 100, we give companies the power to make better decisions, take control of their own future, and capitalize on change.
Associate Director of Marketing
Keith Swiader, Manager
PR & Communications